Evidence map›Paper›PMID 34610213›Full record

ArticleCurrent protocols2021

Modified Cross-Linking, Ligation, and Sequencing of Hybrids (qCLASH) to Identify MicroRNA Targets.

Lauren A Gay, Peter C Turner, Rolf Renne

Open access · hybridAbstract read
In one paragraph

Article in Current protocols, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.4field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Lauren A GayDepartment of Molecular Genetics and Microbiology, University of Florida, Gainesville, Florida.
Peter C TurnerDepartment of Molecular Genetics and Microbiology, University of Florida, Gainesville, Florida.
Rolf RenneDepartment of Molecular Genetics and Microbiology, University of Florida, Gainesville, Florida.
University of Florida · USUniversity of Florida Health · US

Funding

"Project 3" MHV68 IncRNA/miRNA interaction in latency and lympomagenesisP01CA214091 · NCI · UNIVERSITY OF FLORIDA · PI ROLF F RENNE · 2017 to 2026
$15.9M
Studying the role of KSHV-encoded miRNAsR01CA119917 · NCI · UNIVERSITY OF FLORIDA · PI RENNE, ROLF F · 2008 to 2017
$3.2M
Identification of KSHV miRNA targets in endothelial cells and characterization miF31CA180522 · NCI · UNIVERSITY OF FLORIDA · PI GAY, LAUREN APPLEBY · 2013 to 2015
$103k
NCI NIH HHS F31 CA180522NCI NIH HHS P01 CA214091NCI NIH HHS R01 CA119917NIH HHS 5F31 CA180522NIH HHS 5P01 CA214091NIH HHS 5R01 CA119917
6 · The paper itself

Abstract

This protocol was designed to identify microRNA (miRNA) targetomes from smaller-input samples by performing a simplified workflow of the Cross-Linking and Sequencing of Hybrids (CLASH) technique developed in the Tollervey group. In this ribonomics-based technique, Cross-Linking and Immunoprecipitation (CLIP) of Argonaute (Ago) is combined with an RNA ligase reaction that yields covalently bound "hybrids" between miRNAs and their target RNAs. While this iteration of CLIP identifies "high-confidence" or "unambiguous" miRNA targets, the added ligation step is highly inefficient and therefore requires large numbers of cultured cells. To make this powerful approach applicable to smaller cell numbers, we created qCLASH, incorporating a workflow that performs all enzymatic reactions on bead-bound complexes and omits gel purification of immunoprecipitated Ago complexes associated with major loss of RNA. At a sequencing depth of 100 million reads per library, which is highly feasible with rapidly decreasing sequencing costs, qCLASH, when used with three biological replicates, results in thousands of high-confidence miRNA targets. qCLASH was first developed to identify viral miRNA targetomes of endothelial cells infected with Kaposi's sarcoma-associated herpesvirus. Since then, qCLASH has been applied to Epstein-Barr virus- and MHV68-infected cells, and more recently to metastatic melanoma and breast cancer cells. Currently, protocols are under development to apply qCLASH to human solid tumor specimens. © 2021 The Authors. Current Protocols published by Wiley Periodicals LLC. Basic Protocol: Quick Cross-Linking and Sequencing of Hybrids (qCLASH) Support Protocol: Optimization of Ago immunoprecipitation.

Indexed as

Epstein-Barr Virus InfectionsMicroRNAsArgonaute ProteinsEndothelial CellsHerpesvirus 4, HumanHumansArgonaute ProteinsMicroRNAsArgonauteligationMicroRNAqCLASHribonomics

Identifiers

PMID34610213
PMCPMC8500481
OpenAlexW3204246614

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.